Most of these cancers arise in the lymphatic organ, especially B lymphocyte-origin tumors. 3, 4 Nasopharyngeal carcinoma (NPC), an EBVassociated malignant disease, is unique in that it is an epithelial origin tumor and expresses EBV primary oncogene latent membrane protein 1 (LMP1) at the premalignant stage. 2, 5 Normal pharyngeal epithelial cells are a proliferating site for EBV, and EBV infection results in lysis of the infected cell. Thus, switching from lytic EBV infection to a latent one in the epithelium is an initial step in NPC carcinogenesis. 6 Inactivation of the p16 tumor suppressor and overexpression of cyclin D1, commonly detected in the premalignant and dysplastic nasopharyngeal epithelium, may enable the transition to an EBV latent infection in the nasopharyngeal epithelium. 7, 8 Of the 3 types of latent infection, NPC is categorized as a type II infection, which is associated with the expression of 3 virus-encoded proteins (EBV nuclear antigen 1, LMP1, and LMP2) and some virus-encoded RNAs, EBV-encoded small RNAs (EBERs) and BamHI A rightward transcripts (BARTs). Among these EBV gene products, LMP1 has a major role in NPC carcinogenesis (Table 1) . 3, 9 In addition, the importance of the tumor microenvironment is becoming clear with recent progress in the cancer research field.
Here, we review the pathogenic roles of LMP1 in the tumor microenvironment during the development of NPC.
revealed its multipotency to modulate various cell signal transduction pathways, leading to the proliferation and simultaneous suppression of apoptotic programs in LMP1-expressing cells. [11] [12] [13] It is involved in not only cell transformation, but also invasion, metastasis upregulation, cytokine production, immune modulation, and tumor angiogenesis. that EMT activity may be involved in generating stemness in cancer. 21, 22 In particular, LMP1-transformed epithelial cells cause fibroblasts to lose polarity, and upregulation of EMT by LMP1 occurs through upregulation of Twist, Snail, and SatB1 in LMP1-expressing cells. [23] [24] [25] Most oncogenic viruses are capable of stabilizing or enhancing the transcriptional activity of the angiogenic factor hypoxia-inducible factor-1a (HIF-1a), which integrates several biological pathways for viral carcinogenesis. 26, 27 Latent membrane protein 1 also induces HIF-1a. 28 Angiogenesis and lymphangiogenesis surrounding LMP1-expressing cells were also promoted through upregulation of angiogenic factors such as vascular endothelial growth factor, basic fibroblast growth factor, and interleukin-8 (IL-8).
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4 | LATENT MEMBRANE PROTEIN 1 AND
THE WARBURG EFFECT
Aerobic glycolysis, glucose consumption, and lactate production even in the presence of oxygen is called the Warburg effect and is a main hallmark of cancer. 34 The Warburg effect can also be induced by EBV. 35 Latent membrane protein 1 upregulates the HIF-1a pathway regardless of oxygen pressure in the tumor microenvironment. Moreover, glucose is phosphorylated into glucose-6-phosphate in the glycolytic pathway. 36 Hexokinase 2 (HK2) catalyzes the first step in this glycolytic pathway, and thus, overexpression of HK2 is a common feature of cancer.
Latent membrane protein 1 reprograms glycolysis by upregulating HK2, which binds to mitochondria in NPC, and c-Myc is required for LMP1-induced upregulation of HK2. 35 In addition, LMP1 upregulates the receptor for advanced glycation end products (RAGE) in NPC through the activation of nuclear factor-jB, and microvessel count in NPC tumors is associated with the expression of LMP1 and RAGE. Latent membrane protein 1 localizes at the Golgi and multivesicular compartments, and is packaged into exosomes for release from the cell. 40 Exosomes containing LMP1 have been detected in the serum of NPC patients, which induces T-cell anergy and escape from immune surveillance. 41, 42 A nanogram amount of purified recombinant LMP1 strongly suppresses activation of T cells and natural killer (NK) cells. [42] [43] [44] In addition to LMP1 exosomal secretion, LMP1 also increases the concentration and release of basic fibroblast growth factor into exosomes. 32 Latent membrane protein 1 induces the expression of the epidermal growth factor receptor in an EBV-negative epithelial cell line, and exosomes produced by these cells also contain high levels of the epidermal growth factor receptor in exosomes. 41, 45 Latent membrane protein 1 increases the levels of HIF-1a in exosomes, which are then delivered to surrounding tumor cells for EMT induction and pro-metastatic effects. 46 These findings suggest that the effects of EBV and LMP1 on cellular expression also modulate exosome content and properties. It is increasingly evident that viruses, such as EBV, can hijack and utilize the host cell exosome pathway to modulate cell-cell signaling and control the tumor microenvironment.
| INTER ACTION WITH STROMAL CELLS
A dense infiltration of lymphocytes, called lymphoepithelioma, is a well-known pathological characteristic of NPC. 47 In addition to exosomal secretion of LMP1, the close association of EBV infection with lymphoepithelioma-like carcinoma implies that the poorly differenti- 48 The CD8 + T-cell responses to LMP1 are generally low and rarely detected in healthy virus carriers. In addition to exosomemediated immune modification, EBV has multiple ways to escape from immune attack. 49, 50 Latent membrane protein 1 localizes to lipid rafts in the cell membrane when aggregated. 51 An LMP1 mutant that cannot aggregate at lipid rafts is recognized by HLA epitope-sensitized CTLs, but WT and LMP mutants that retain aggregation and localization to stroma. 47 Expression of LMP1 prevents epithelial cell differentiation. 62 Interaction of NPC tumor cells with TIL is thought to be maintained through cytokine production and exosome excretion. 
| CON CLUDING REMARKS
Although EBV products, including LMP1, enhance the invasive and metastatic capabilities of EBV-infected malignant cells, the overall impact of EBV for the prognosis of NPC patients is somewhat limited. 67 Similar to human papillomavirus (HPV)-associated oropharyngeal carcinoma, which has a better prognosis than non-HPVassociated oropharyngeal carcinoma, patients with EBV-associated NPC have a better prognosis compared to patients with non-EBVassociated NPC. 47, 68, 69 This might seem contradictory considering the results discussed in this review, but EBV-associated NPC is sensitive to chemoradiotherapy treatment and immune checkpoint inhibitors.
LMP1 is not the only EBV gene expressed in NPC. Emerging evidence has revealed that EBV-encoded non-coding RNAs, such as EBERs, BARTs, and miR-BARTs, also contribute directly to NPC development. For example, EBERs contribute to immune evasion by inducing IL-10 through protein kinase R-independent pathways. 70 Thus, the function of these abundantly expressed RNAs suggests an interplay with tumor cells and the microenvironment. 
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Finally, investigation into the role of heavily infiltrated lymphoid stroma will be important for understanding the pathogenic role of EBV in epithelial malignancies, including NPC. Hopefully, this will provide clues to develop new therapeutic targets in addition to emerging immune checkpoint inhibitors.
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